Literature DB >> 25751759

Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.

Jesper F Christensen1, Mikkel Bandak, Anna Campbell, Lee W Jones, Pernille Højman.   

Abstract

BACKGROUND: Treatment of testicular germ cell cancer constitutes a major success story in modern oncology. Today, the vast majority of patients are cured by a therapeutic strategy using one or more highly effective components including surgery (orchiectomy), radiotherapy and/or chemotherapy. However, the excellent cancer-specific survival comes at considerable costs, as individuals with a history of germ cell cancer experience serious long-term complications, including markedly increased risk of cardiovascular morbidities and premature cardiovascular death. The factors responsible, as well as their mode of action, are not fully understood and there is a lack of knowledge concerning optimal evidence-based long-term follow-up strategies.
RESULTS: Here, we present the growing body of evidence suggesting that germ cell cancer patients as a consequence of the different treatment components, are subjected to toxicities, which individually, and synergistically, can cause physiological impairments leading to sub-clinical or clinical cardiovascular disorders (i.e. the 'multiple-hit hypothesis'). Furthermore, we discuss the efficacy and utility of structured exercise training to ameliorate treatment-induced cardiovascular dysfunction to prevent premature onset of clinical cardiovascular disease in germ cell cancer survivors, with a view towards highlighting future directions of exercise-based survivorship research in the germ cell cancer setting.
CONCLUSION: As exercise training may have the potential to ameliorate and/or reverse long-term cardiovascular disease sequelae in germ cell cancer survivors, a strong rationale exists for the promotion of exercise oncology research in this setting, in order to provide exercise recommendations for optimal germ cell cancer survivorship.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751759      PMCID: PMC5020419          DOI: 10.3109/0284186X.2014.995776

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  38 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

Review 2.  Skeletal muscle glucose uptake during exercise: how is it regulated?

Authors:  Adam J Rose; Erik A Richter
Journal:  Physiology (Bethesda)       Date:  2005-08

Review 3.  Testicular cancer variations in time and space in Europe.

Authors:  Eric Huyghe; Pierre Plante; Patrick F Thonneau
Journal:  Eur Urol       Date:  2006-08-30       Impact factor: 20.096

Review 4.  Updated evidence in support of diet and exercise interventions in cancer survivors.

Authors:  Dorothy W Pekmezi; Wendy Demark-Wahnefried
Journal:  Acta Oncol       Date:  2010-11-24       Impact factor: 4.089

Review 5.  Exercise-induced myokines and their role in chronic diseases.

Authors:  Bente K Pedersen
Journal:  Brain Behav Immun       Date:  2011-02-25       Impact factor: 7.217

6.  The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

Authors:  Janine Nuver; Andries J Smit; Bruce H R Wolffenbuttel; Wim J Sluiter; Harald J Hoekstra; Dirk T Sleijfer; Jourik A Gietema
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

7.  Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.

Authors:  Alexandra W van den Belt-Dusebout; Janine Nuver; Ronald de Wit; Jourik A Gietema; Wim W ten Bokkel Huinink; Patrick T R Rodrigus; Erik C Schimmel; Berthe M P Aleman; Flora E van Leeuwen
Journal:  J Clin Oncol       Date:  2006-01-20       Impact factor: 44.544

8.  Treatment of testicular cancer: a new and improved model.

Authors:  L H Einhorn
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

9.  Mortality after cure of testicular seminoma.

Authors:  Gunar K Zagars; Matthew T Ballo; Andrew K Lee; Sara S Strom
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

10.  Resistance training does not protect against increases in plasma cytokine levels among germ cell cancer patients during and after chemotherapy.

Authors:  Jesper F Christensen; Anders Tolver; Jesper L Andersen; Mikael Rørth; Gedske Daugaard; Pernille Hojman
Journal:  J Clin Endocrinol Metab       Date:  2014-07-22       Impact factor: 5.958

View more
  8 in total

Review 1.  Anaesthesia for retroperitoneal lymph node dissection in the treatment of testicular cancer.

Authors:  M Stephens; T Murphy; D Hendry
Journal:  BJA Educ       Date:  2019-07-05

Review 2.  Long-term toxicity of cisplatin in germ-cell tumor survivors.

Authors:  M Chovanec; M Abu Zaid; N Hanna; N El-Kouri; L H Einhorn; C Albany
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

3.  Psychological Needs Satisfaction, Self-Rated Health and the Mediating Role of Exercise Among Testicular Cancer Survivors.

Authors:  Anika R Petrella; Catherine M Sabiston; Madison F Vani; Andrew Matthew; Daniel Santa Mina
Journal:  Am J Mens Health       Date:  2021 Mar-Apr

Review 4.  Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.

Authors:  Chunkit Fung; Paul Dinh; Shirin Ardeshir-Rouhani-Fard; Kerry Schaffer; Sophie D Fossa; Lois B Travis
Journal:  Adv Urol       Date:  2018-02-18

5.  Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer.

Authors:  Lene Thorsen; Camilla Kirkegaard; Jon Håvard Loge; Cecilie E Kiserud; Merethe Lia Johansen; Gunhild M Gjerset; Elisabeth Edvardsen; Hanne Hamre; Tone Ikdahl; Sophie D Fosså
Journal:  BMC Res Notes       Date:  2017-06-15

6.  Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors.

Authors:  Scott C Adams; Darren S DeLorey; Margie H Davenport; Adrian S Fairey; Scott North; Kerry S Courneya
Journal:  Br J Cancer       Date:  2018-05-08       Impact factor: 7.640

Review 7.  Myocardial Ischemia Related to Common Cancer Therapy-Prevention Insights.

Authors:  Minerva Codruta Badescu; Oana Viola Badulescu; Dragos Viorel Scripcariu; Lăcrămioara Ionela Butnariu; Iris Bararu-Bojan; Diana Popescu; Manuela Ciocoiu; Eusebiu Vlad Gorduza; Irina Iuliana Costache; Elena Rezus; Ciprian Rezus
Journal:  Life (Basel)       Date:  2022-07-12

Review 8.  Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell Tumors.

Authors:  Ratnakar Singh; Zeeshan Fazal; Sarah J Freemantle; Michael J Spinella
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.